Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Motesanib diphosphate: Final Phase Ib data

In an open-label, international Phase Ib trial (153) in 45 patients with advanced

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE